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ABSTRACT
Introduction. !e aim of the study was to 
determine intubation conditions in the 
patients receiving rocuronium in compari-
son to succinylcholine for rapid sequence 
intubation during the induction of anes-
thesia for operative management of bowel 
obstruction. 
Methods. In the randomized controlled 
study 30 adult patients with bowel obstruc-
tion undergoing urgent surgery were ran-
domly allocated in two groups. For muscle 
relaxation the S-group of patients received 
succinylcholine (1.5 mg/kg) and the R-
group rocuronium (1.2 mg/kg). Intubation 
conditions were evaluated using a grad-
ing system according to Viby-Morgenson. 
Primary outcomes were intubation con-
ditions 1 minute a"er the application of 
a muscle relaxant. Secondary outcome 
measures were heart rate, blood pressure, 
and pulse oximetry; potassium and myo-
globin serum level.
Results. All patients were orotracheally 
intubated in the #rst attempt. During in-
duction, we didn’t observe vomiting or as-
piration. Overall intubation conditions in 
the S-group were statistically signi#cantly 
better than in the R-group. A"er RSI there 
was a statistically signi#cant decrease in 
systolic and diastolic blood pressure in 
both groups and statistically signi#cant 
decrease in heart rate in the S-group. A"er 
RSI the potassium level in the S-group was 
signi#cantly higher in comparison to the 
R-group and serum myoglobin level non-
signi#cantly increased in the S-group and 
statistically signi#cantly decreased in the 
R-group.
Conclusion. !e results show that rocuro-
nium in RSI patients with bowel obstruc-
tion enables the same intubation condi-
tions as succinylcholine and the same risk 
of aspiration which allows succinylcholine 
replacement and avoidance of its side ef-
fects.
Key words: Rocuronium, succinylcholine, 
rapid sequence intubation, bowel obstruc-
tion, intubation conditions
INTRODUCTION
Bowel obstruction is a common surgical 
emergency o"en requiring urgent opera-
tive management (1).
Patients with bowel obstruction have an 
increased risk of vomiting and pulmonary 
aspiration of gastric content and require 
rapid sequence intubation (RSI) during 
the induction of anesthesia (2–4). RSI is 
a well-de#ned medical procedure used in 
urgent airway management in critically ill 
patients and during the induction of anes-
thesia (4 – 8).
!e most commonly used muscle relaxant 
to perform RSI in the past and still today 
is the depolarizing muscle relaxant succi-
nylcholine because of its excellent pharma-
cokinetic features (9, 10). Succinylcholine 
has a rapid onset and short duration of 
action. In case of di$cult or failed orotra-
cheal intubation, muscle relaxation is rap-
idly resolved; the patient starts breathing 
spontaneously, and the risk of pulmonary 
aspiration is reduced. Unfortunately, suc-
cinylcholine can cause several adverse side 
e%ects a%ecting blood pressure and heart 
rate, causing fasciculations, muscle pain 
and prolonged paralysis, elevated intragas-
tric, intraocular and intracranial pressure, 
hyperkalemia, masseter muscle rigidity, 
malignant hyperthermia, generalized con-
tractions, and histamine release (3, 11-13).
Rocuronium is a non-depolarizing mus-
cle relaxant with rapid onset of action and 
fewer side e%ects than succinylcholine (10, 
11, 13, 14, 16). At a higher dose it has an 
onset of action that approaches succinyl-
choline, making it a suitable alternative for 
RSI. Even though rocuronium has a longer 
duration of action, neuromuscular block 
can be neutralized with sugammadex in 
the case of a failed RSI, even when neuro-
muscular block is deep (11, 15 -18).
Rocuronium has much less side e%ects 
compared to succinylcholine, particularly 
in critically ill patients with bowel obstruc-
tion (3, 11). However, the quality of vo-
cal cord visualization, which is crucial for 
successful orotracheal intubation, is better 
with succinylcholine (19).
Succinycholine and rocuronium can cause 
anaphylactic reaction, but using suc-
cinycholine for RSI carries almost twice 
the greater risk for anaphylactic reaction 
compared to rocuronium (38).
!e aim of the study was to compare in-
tubation conditions in patients receiving 
rocuronium in comparison with patients 
receiving succinylcholine for RSI during 
the induction of anesthesia for operative 
management of bowel obstruction. 
METHODS
!e study was approved by the Republic of 
Slovenia National Medical Ethics Commit-
tee - NMEC on 29 October 2013 (registra-
tion number 104/10/13) and retrospective-
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ly registered with the ISRCTN registry on 
4 December 2015 (Ref: ISRCTN11777647; 
20).
All patients provided a signed informed 
consent before randomization. Adults old-
er than 18 years with the American Society 
of Anesthesiology physical (ASA) status 
classes 2 and 3, who had bowel obstruction 
and were scheduled for an urgent surgery 
at the University Medical Centre Maribor 
between December 2013 and June 2016, 
were enrolled in the randomized con-
trolled study.
!e exclusion criteria were increased 
serum potassium level, severe acute or 
chronic renal failure, Mallampaty score 3 
or 4, and history of allergy to any of medi-
cations used in our protocol, patient ASA 
score more than 3 and patient refusing to 
participate in the study. 
Patients were randomly allocated before 
surgery to either the succinylcholine group 
(S-group) or rocuronium group (R-rocu-




Patients did not receive any premedication. 
In the operating room the nasogastric tube 
and peripheral venous catheter 16-G were 
inserted. !e gastric content was aspirated 
through the nasogastric tube as much as 
possible. !e patients were preoxygenated 
through the facemask with a &ow of 10l/
min for 5 minutes. Before the induction of 
anesthesia, patients were monitored with 
electrocardiography, noninvasive blood 
pressure measurement, and pulse oxime-
try. Radial artery line was inserted and the 
relaxometer TOF-Watch S (Organon) was 
initiated on the opposite side of the arterial 
catheter.
Patients received a bolus of midazolam 
0.05mg/kg body weight (b.w.) and fen-
tanyl 2 µg/kg b.w. before the relaxometer 
was calibrated. A"er calibration in the R-
group, TOF was measured 60 seconds a"er 
muscular relaxant application. !e patients 
were positioned in the head-down position 
and the gastric content was once again as-
pirated. !e induction of anesthesia and 
orotracheal intubation was performed ac-
cording to the RSI protocol.
!e induction to the anesthesia was con-
tinued with etomidate 0.3mg/kg b.w. Pa-
tients in the S-group received succinyl-
choline 1.5mg/kg b.w. and the patients in 
R-group received rocuronium 1.2mg/kg 
b.w. !e Selick maneuver was performed. 
Indirect laryngoscopy and orotracheal in-
tubation with Macintosh laryngoscope was 
performed 60 seconds a"er the induction.
Data collection 
We collected patients demographic data 
(age, sex, height, weight), ASA status and 
hemodynamic measurements 1 minute be-
fore the induction and 1 minute a"er oro-
tracheal intubation (blood pressure, heart 
rate and pulse oximetry), clinical intubat-
ing conditions (assessed by the anesthesi-
ologist), intubating conditions according 
to the Viby-Morgenson score system (table 
1), number of orotracheal intubation at-
tempts, vomiting, aspiration, oropharyn-
geal and laryngeal pain a"er extubation. 
Blood samples for serum potassium and 
myoglobin measurement were collected 
through a radial artery line before the in-
duction of anesthesia and 5 minutes a"er 
the muscular relaxant application. 
Study outcomes
Primary outcomes were intubation condi-
tions 1 minute a"er the muscular relax-
ant application, determined by response 
to laryngoscopy, vocal cord position and 
movement, and response to intubation. 
Secondary outcome measures were: heart 
rate, blood pressure and pulse oximetry, 
measured 1 minute before and a"er the 
orotracheal intubation; potassium and 
myoglobin serum level measured 5 minute 
before and a"er the muscle relaxant appli-
cation.
Statistics
Data were analyzed with the IBM SPSS 
Statistics statistical so"ware version 19.0 
(SPSS Inc., Chicago, IL, USA). Patients’ 
characteristics and baseline values were 
compared using a t-test for independent 
samples, the Kruskal Wallis test, and χ2 
where appropriate. !e t-test for inde-
pendent samples was performed to com-
pare the hemodynamic data between the 
two groups and t-test for paired samples 
to compare the hemodynamic data before 
and a"er intubation with baseline values. 
Data are presented as mean value ± stand-




We enrolled 46 patients with bowel ob-
struction who underwent urgent operative 
management and RSI during the induction 
of anesthesia. Sixteen patients were exclud-
ed from the study due to increased serum 
potassium, renal failure, increased Mal-
lampaty, and ASA score. !irty patients 
were randomly allocated into S-group or 
R-group (Figure 1).
!ere were no statistically signi#cant dif-
ferences between both groups according to 
main demographic characteristics Table 2. 
All patients in both groups were orotrache-
ally intubated in the #rst attempt. During 
RSI no vomiting or aspiration occurred in 
any of the patients.
Overall intubation conditions in both 
groups are listed in Table 3, according to 
the grading system for intubation (Table 
1). Intubation conditions in S-group were 
excellent in 80% of patients and good in 
20% of patients. In R-group, intubation 
conditions were excellent in 40% of pa-
tients and good in 60% of patients. In both 
groups we did not observe any patients 
Figure 1 Study &ow diagram
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with poor intubation conditions. Intuba-
tion conditions in S-group were statisti-
cally signi#cantly better than in R-group of 
patients (Table 3).
!ere were no statistically signi#cantly 
di%erences between groups comparing 
individual parameters which determine 
overall intubating conditions according 
to the grading system score designed by 
Viby-Morgenson et al. (Table 4; 22). In 
both groups we observed no resistance 
to laryngoscopy (Table 4). We observed 
better vocal cord position in the S-group, 
which was not statistically signi#cant. In 
the R-group we observed one reaction to 
intubation with a slight limb movement 
and one movement of vocal cords during 
orotracheal intubation (Table 4)
!ere were no statistically signi#cant dif-
ferences in systolic and diastolic blood 
pressure before and a"er RSI between the 
groups (table 5). !ere was a statistically 
signi#cant decrease in the systolic and 
diastolic blood pressure a"er RSI in both 
groups (table 5).
Before RSI there were no signi#cant di%er-
ences in the heart rate between the groups. 
A"er RSI, there was a statistically signi#-
cant decrease in the heart rate in the S-
group, while in the R-group we observed a 
small increase in the heart rate, which was 
not statistically signi#cant (table 5).
!ere were no statistically signi#cant dif-
ferences in oxygen saturation–between the 
groups before and a"er RSI (table 5).
!ere were no signi#cant di%erences be-
tween groups in serum potassium level be-
fore RSI, but a"er RSI the potassium level 
in the S-group was signi#cantly higher in 
comparison to the R-group (Table 6). Af-
ter the induction the potassium level in-
creased signi#cantly in the S-group and 
statistically signi#cantly decreased in the 
R-group.
!ere were no signi#cant di%erences be-
tween groups in serum myoglobin level 
before and a"er RSI, but a"er RSI serum 
myoglobin level increased in the S-group 
(which was not statistically signi#cant) 
and statistically signi#cantly decreased in 
the R-group (Table 6).
 
Table 1. Grading system for intubation conditions according to Viby-Morgenson et al. (22).
Excellent Good Poor
Laryngoscopy
Jaw relaxation Relaxed Relaxed Poor relaxation
Resistance to blade No resistance Slight resistance Active resistance
Vocal cords
Position Abducted Intermediate Closed
Movement None Moving Closing
Reaction to intubation
Limb movement None Slight Vigorous
Coughing None Diaphragm Sustained
Legend: !e overall intubating conditions were graded excellent if all observed parameters were excellent. If the observed parameters 
were good and excellent the intubating conditions were graded good. If one or more parameters were poor, the intubating conditions 
were graded poor.
Table 2. Demographic data of the patients.
Demographic data S-group R-group P value
Age (year) 63.1 ± 16.1 61.7± 13.0 0.795
Male / female (n) 9 / 6 11 / 4 0.439
Height (cm) 167.6 ± 10.3 169 ± 7.1 0.625
Weight (kg) 69.3 ± 16.3 67.2 ± 7.1 0.740
ASA value (2 / 3) 1 / 14 1 /14 1
Legend: mean value ± SD, *statistically signi#cant, S-group = succinylcholine group, R-group = rocuronium group
Table 3. Overall intubation conditions in the patients
S-group R-group P value












Legend: *statistically signi#cant, S - group = succinylcholine group, R - group= rocuronium group
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Table 4. Evaluation of intubating conditions in patients according to the grading system score designed by Viby-Morgenson et al. (22).
Grading system score S-group R-group P value






































































Legend: *statistically signi#cant, S-group = succinylcholine group, R-group= rocuronium group
Table 5. Hemodynamic data and laboratory data of patients before and a'er intubation (S-group = succinylcholine group; R-group = 
rocuronium group).
Hemodynamic data
(mean value ± SD) S-group R-group P value
SBP before RSI (mmHg) 156.4 ± 26.1 154.8 ± 28.5 0.874
a"er RSI (mmHg) 114.7 ± 26.0** 117.9 ± 22.5** 0.715
DBP before RSI (mmHg) 84.5 ± 13.6 86.6 ± 10.1 0.629
a"er RSI (mmHg) 66.0 ± 12.4** 67.8 ± 11.6** 0.685
HR before RSI (beats / min) 90.5 ± 18.5 92.9 ± 14.6 0.696
a"er RSI (beats / min) 78.9 ± 18.1** 94.4 ± 18.2 0.027*
SpO2 before RSI (%) 98.9 ± 0.8 99.1 ± 1.0 0.548
a"er RSI (%) 98.5 ± 1.4 99.1 ± 1.0 0.145
Potassium before RSI (mmol/l) 3.9 ± 0.3 3.9 ± 0.4 0.741
a"er RSI (mmol/l) 4.0 ± 0.3 3.7 ± 0.4** 0.019*
Myoglobin before RSI (μg/l) 74.5 ± 53.4 80.9 ± 76.1 0.794
a"er RSI (μg/l) 82.7 ± 52.3 75.5 ± 71.6** 0.755
Legend: SBP – systolic blood pressure, HR – heart rate, RSI – rapid sequence intubation, DBP – diastolic blood pressure, SpO2 – pulse 
oximetry, SD – standard deviation, mean value ± SD
*- statistically signi#cant between groups
**- statistically signi#cant within group before and a"er intubation
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DISCUSSION
Our study aimed to compare the intuba-
tion conditions in 30 patients with bowel 
obstruction using two di%erent muscle re-
laxants. We compared 1.5mg/kg succinyl-
choline and 1.2mg/kg rocuronium, which 
are the dosages that should provide rapid 
and best intubation conditions (23, 28). 
Indirect laryngoscopy was performed 60 
seconds a"er the injection of muscle relax-
ant. All patients in both groups were suc-
cessfully intubated in the #rst attempt.
We observed statistically signi#cant bet-
ter intubation conditions in patients in the 
S-group than in R-group (table 3), accord-
ing to the grading system score designed 
by Viby-Morgenson (22). But comparing 
individual parameters, which determine 
intubating condition according to grading 
system score designed by Viby-Morgenson 
there were no statistically signi#cantly dif-
ferences between groups (Table 4). !e 
main di%erence between the groups was in 
the vocal cords position (Table 4). Accord-
ing to our study, rocuronium 1.2mg/kg 
b.w. allowed excellent and good intubation 
conditions which are accepted as clinically 
good enough for successful orotracheal 
intubation, without increased incidence of 
aspiration. 
Based on our results, we agree with the 
report by McCourt et al. that rocuronium 
1mg/kg b.w. provides excellent and good 
intubation conditions, ful#lling the condi-
tions for acceptable intubation conditions 
in the patients who are undergoing elec-
tive or emergency surgery (24). Luxen et 
al. also concluded that rocuronium, which 
has less side e%ects and nearly the same in-
tubation condition, can be a good replace-
ment for succinylcholine in intubation of 
emergency department patients (25).
Contrary to our results, Perry J et al. in the 
Cochrane review in 2003 compared intu-
bating conditions between rocuronium 
0.6mg/kg and succinylcholine 1mg/kg. 
!ey concluded the conditions were bet-
ter when succinylcholine was used (26). 
In the last Cochrane review in 2017 Tran 
et al. compared intubation conditions be-
tween rocuronium 1.2mg/kg and succinyl-
choline 1mg/kg and found no statistically 
signi#cant di%erence in intubation condi-
tions. Despite their statistical results, they 
concluded due to succinylcholine shorter 
duration of action that succinylcholine 
created superior intubation conditions to 
rocuronium in achieving excellent and 
clinically acceptable intubating conditions 
and rocuronium should only be used as an 
alternative to succinylcholine (27). Based 
on our results, we cannot agree with such 
conclusion, because rocuronium 1.2mg/
kg allowed excellent clinical intubation 
conditions and has more properties as an 
'ideal' muscle relaxant for RSI than succi-
nylcholine (28 - 31).
!ere were no statistically signi#cant dif-
ferences in systolic blood pressure in 
both groups before and a"er induction of 
anesthesia. A"er the induction a statisti-
cally signi#cant decrease in systolic blood 
pressure was observed in both groups. !e 
decrease in systolic blood pressure was the 
consequence of induction drugs and me-
chanical ventilation a"er induction. 
Heart rate decreased a"er RSI in the S-
group but not in the R-group with statis-
tically signi#cant di%erences between the 
groups. Bradycardia is a well-known ad-
verse e%ect of succinylcholine, which can 
also in&uence blood pressure, especially in 
critical ill patients undergoing emergency 
surgery due to bowel obstruction (9).
We observed an increase in potassium and 
myoglobin levels a"er RSI in the S-group 
and slight decrease in the R-group. Change 
in potassium levels between the groups was 
statistically signi#cant. Sabo et al. also con-
cluded that succinylcholine was associated 
with a modest increase in potassium con-
centration and these changes were not seen 
a"er rocuronium or sugammadex applica-
tion (32). In some patients with acquired 
pathologic state, hyperkalemic response to 
succinylcholine can be remarkable, caus-
ing ventricular #brillation and death (33, 
34). In the literature some authors recom-
mend precurarization with rocuronium 
before succinylcholine administration to 
reduce the incidence and severity of fascic-
ulations and prevent an increase in serum 
potassium and myoglobin concentrations 
in adults and children (35-37). 
But in our opinion, it is better to avoid using 
muscle relaxant with such life-threatening 
side e%ects and risk for anaphylactic reac-
tion, which is higher if compared to rocuro-
nium and then, a"er RSI, another interme-
diately acting neuromuscular blocking drug 
has to be used, with its own risk for anaphy-
lactic reaction, to maintain neuromuscular 
block during abdominal surgery (38).
We have to emphasize that in our study in 
both groups of patients we did not observe 
any regurgitation or aspiration, which are 
the major life-threatening complications 
during RSI in patients with bowel obstruc-
tion.
CONCLUSION
!e results in the present study indicate 
that rocuronium in RSI patients with bowel 
obstruction enables the same intubation 
conditions as succinylcholine and the same 
risk of aspiration which allows succinyl-




RSI: rapid sequence intubation; SBP: sys-
tolic blood pressure; DBP: diastolic blood 
pressure; SpO2: pulse oximetry; HR: heart 
rate; SD: standard deviation; S-group: suc-
cinylcholine group; R-group: rocuronium 
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